1
Clinical Trials associated with Group A and Group C Meningococcal Conjugate Vaccine(Sinovac Life Sciences) / Not yet recruitingPhase 1 评价冻干A群C群脑膜炎球菌多糖结合疫苗在18~59岁人群中安全性的开放性Ⅰa期临床试验
[Translation] An open-label phase Ⅰa clinical trial to evaluate the safety of freeze-dried group A and group C meningococcal polysaccharide conjugate vaccine in people aged 18 to 59 years
评价北京科兴中维生物技术有限公司研发的冻干A群C群脑膜炎球菌多糖结合疫苗在18~59岁人群中的安全性。
[Translation] To evaluate the safety of the freeze-dried group A and group C meningococcal polysaccharide conjugate vaccine developed by Beijing Sinovac Biotech Co., Ltd. in people aged 18-59 years.
100 Clinical Results associated with Group A and Group C Meningococcal Conjugate Vaccine(Sinovac Life Sciences)
100 Translational Medicine associated with Group A and Group C Meningococcal Conjugate Vaccine(Sinovac Life Sciences)
100 Patents (Medical) associated with Group A and Group C Meningococcal Conjugate Vaccine(Sinovac Life Sciences)
100 Deals associated with Group A and Group C Meningococcal Conjugate Vaccine(Sinovac Life Sciences)